Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease.
Phase II
· Site: 703 (USA) (Dr. Okafor)
· consented 2013-09-22
Adverse events
0
Serious AEs
0
Open data queries
0
Luna dropout signal
–
Adverse events
No adverse events recorded.
Data queries
No data queries.
☾ Luna engagement
This participant doesn't use Luna.